YCBD cbdMD Inc.: Enterprise Value to EBITDA Ratio
The optimization of internal processes at cbdMD, Inc. (YCBD) is aimed at maintaining operational efficiency and the stable cash flow generated by the retail segment. The brand is implementing progressive extraction methods and strict laboratory oversight to create safe wellness products. The company generates revenue from the sale of CBD products for humans and animals via e-commerce, while the 0.00 metric is recorded on an EV/EBITDA valuation chart used as an assessment tool.
Comprehensive metric breakdowns and analytics for cbdmd.com (YCBD)
- market price and analyst price targets:
- company stock capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
YCBD - Net Income|Projected Future Earnings cbdMD, Inc.|YCBD - Price to Earnings Multiple|Projected Price to Earnings cbdMD|YCBD - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple cbdMD, Inc.|YCBD - Operating income before deduction of amortization|Earnings per share for the last twelve months cbdMD|YCBD - Earnings per share for the last 12 months|Quarterly EPS earnings growth cbdmd.com|YCBD - Net earnings per share growth this year|Expected earnings per share growth for next year cbdMD, Inc.
Analysis of all company metrics:cbdMD Corp YCBD
Fundamental asset selection is based on comparing a business's market value with its actual ability to generate cash flow. The EV/EBITDA ratio measures the total enterprise value, including net debt, relative to operating profit before interest, taxes, depreciation, and amortization, helping to identify undervalued assets. The efficiency of recruiting IT talent and marketers at cbdMD, Inc. (YCBD) directly impacts profit growth, which is reflected in the trajectory of the company's EV/EBITDA value.
Who cbdMD, Inc. competes with
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Haleon Group HLN|Kenvue Health (KVUE) - Company Value to EBITDA|VRNA: Enterprise Value to EBITDA Ratio|jyongbio.com - Enterprise Value to Operating Income Before Depreciation Ratio|LGND: EV/EBITDA Multiple|Amneal Pharmaceuticals, Inc. - Business Value to Operating Income Before Depreciation|PRGO (Perrigo Company) - EV/EBITDA Multiple|Company Value to EBITDA Alvotech Biopharmaceuticals ALVO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Liquidia Corporation (LQDA)|GLPG (glpg.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ANIP (ANI Pharmaceuticals, Inc.)|MNKD - Enterprise Value to EBITDA Ratio|Amphastar - EV/EBITDA Multiple|PCRX: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SPRY: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation TBPH|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aquestive Therapeutics, Inc.|Enterprise Value to EBITDA Ratio scPharma (SCPH)|EV/EBITDA Multiple TECX|Tonix Pharmaceuticals Holding - Enterprise Value to Operating Income Before Depreciation|China SXT Pharmaceuticals, Inc. - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation EPRX|BioHarvest Sciences Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Invizyne Technologies EXOZ|oramed.com (ORMP) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation ENTX|HYFT (MindWalk Holdings) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio abvcpharma.com (ABVC)|Enterprise Value to EBITDA Ratio CPIX (Cumberland Pharmaceuticals Inc.)|Total Company Value to Operating Income Before Depreciation Ratio Quantum BioPharma Ltd.|FibroGen Corp - Enterprise Value to EBITDA Ratio|Telomir Pharmaceuticals Corp (TELO) - Company Value to EBITDA|Rani Therapeutics Inc - EV/EBITDA Multiple|Synergy CHC Corp (SNYR) - Enterprise Value to EBITDA Ratio|RLYB: EV/EBITDA Multiple|LEXX (Lexaria Bioscience Corp.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|PULM (Pulmatrix Corp) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation PTHL (Pheton)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aptorum Group Limited (APM)|LYRA: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple IBO (Impact BioMedical)|Business Value to Operating Income Before Depreciation TNFA|PainReform Limited - EV/EBITDA Multiple|CYTO - EV/EBITDA Multiple|Lipella Pharmaceuticals (LIPO) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|optinose.com - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pieris Pharmaceuticals, Inc.|Enterprise Value to EBITDA Ratio Procaps Group (PROC)|EV/EBITDA Multiple PTPI|EV/EBITDA Multiple Qilian International Corp (QLI)|Acelyrin, Inc. - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation TFFP
